BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4212668)

  • 1. [Hemophilia BM (abnormal factor IX in coagulation disorder) (author's transl)].
    Girolami A; Cella G; Patrassi G
    Haematologica; 1974 Mar; 59(1):91-108. PubMed ID: 4212668
    [No Abstract]   [Full Text] [Related]  

  • 2. The genetic heterogeneity of hemophilia B.
    Brown PE; Hougie C; Roberts HR
    N Engl J Med; 1970 Jul; 283(2):61-4. PubMed ID: 5420360
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of severe haemophilia B with a factor IX concentrate (author's transl)].
    Ludwig E; Lechner K
    Dtsch Med Wochenschr; 1974 Jun; 99(25):1355-61. PubMed ID: 4836072
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the prolonged prothrombin time in haemophilia BM.
    Elödi S
    Thromb Diath Haemorrh; 1973 May; 29(2):247-52. PubMed ID: 4796945
    [No Abstract]   [Full Text] [Related]  

  • 6. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 7. Variants of haemophilia B.
    Elödi S; Puskás E
    Thromb Diath Haemorrh; 1972 Dec; 28(3):489-95. PubMed ID: 4675270
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor IX Deventer-evidence for the heterogeneity of hemophilia BM.
    Bertina RM; van der Linden IK
    Thromb Haemost; 1982 Apr; 47(2):136-40. PubMed ID: 7101232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty.
    Briët E; Bertina RM; van Tilburg NH; Veltkamp JJ
    N Engl J Med; 1982 Apr; 306(13):788-90. PubMed ID: 7062952
    [No Abstract]   [Full Text] [Related]  

  • 10. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M; TANAKA M
    Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
    [No Abstract]   [Full Text] [Related]  

  • 11. An investigation of three patients with Christmas disease due to an abnormal type of factor IX.
    Denson KW; Biggs R; Mannucci PM
    J Clin Pathol; 1968 Mar; 21(2):160-5. PubMed ID: 4972271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new concentrate for the treatment of factor IX deficiency.
    Gilchrist GS; Ekert H; Shanbrom E; Hammond D
    N Engl J Med; 1969 Feb; 280(6):291-5. PubMed ID: 5762370
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemophilia B+ or Bm. First case reported in Italy.
    Girolami A; Cella G; Bareggi G
    Blut; 1973 Apr; 26(4):268-79. PubMed ID: 4700225
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of the deficient factor in hemophilic patients].
    Peñaloza-Santillán JA; Arias y Arias J; Resano-Pérez F
    Bol Med Hosp Infant Mex; 1975; 32(1):51-9. PubMed ID: 1109289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of vitreous body in the blood coagulation].
    Regnault F; Larrieu MJ
    Pathol Biol (Paris); 1969 Jan; 17(1):31-7. PubMed ID: 4895968
    [No Abstract]   [Full Text] [Related]  

  • 16. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemophilia Bm: a new type of factor-IX deficiency.
    Hougie C; Twomey JJ
    Lancet; 1967 Apr; 1(7492):698-700. PubMed ID: 4163943
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of recombinant factor IX and thromboelastography in a patient with hemophilia B undergoing liver transplantation: a case report.
    De Pietri L; Masetti M; Montalti R; Begliomini B; Reggiani A; Barbieri E; Biagioni E; Marietta M; Romano A; Pasetto A; Gerunda GE
    Transplant Proc; 2008; 40(6):2077-9. PubMed ID: 18675136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources.
    Lefkowitz JB; Monroe DM; Kasper CK; Roberts HR
    Am J Hematol; 1993 Jul; 43(3):177-82. PubMed ID: 8352232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.